Eli Lilly Abandons Weight Loss Pill Trials!
This episode of On The Pen: The Weekly Dose Podcast breaks down four major stories in obesity medicine: the FDA’s approval of Teva’s so-called “generic” Saxenda at a sky-high price, Wegovy’s accelerated approval in MASH, Novo Nordisk’s headline-grabbing but shaky 57% cardiovascular benefit claim, and Eli Lilly’s decision to scrap its oral GLP-1 naperiglipron. We cut through the spin to ask what these developments really mean for patients fighting for access and better treatment options.
Visit All Our Links
https://linktr.ee/manonthemounjaro
GLP-1 Heart Study
https://onthepen.substack.com/p/new-study-glp-1-drugs-protect-the
As seen on YouTube.
Related in [Weight loss]:
- Best Weight Loss Diet || Best Weight Loss Tips For Women #pcodcure #doctorsvlog #intermittentfasting
- Jeera Water For Weight Loss ( Health Benefits) – Dietitian Mac Singh
- 20 Min Morning Yoga For Weight Loss | Fat-Burning Yoga Flow At Home
- Budget Friendly Weight Loss Meals | Full Recipe In Description
- Diabetes Weight Loss Success Story
Other posts:
- Yoga For Strong Back For Kids | Improve Strength & Posture | Yoga For Children | Yogachild
- Immunity To All Forms Of The Coronavirus May Be Closer Than We Thought | COVID-19 Special
- How To Get Your 10,000 STEPS A DAY The Easy Way | TOP 5 TIPS
- Men In Black International Trailer #1 (2019) | Movieclips Trailers
- LIVE : Maha Shivaratri 2023 | Sadhguru | Live From Isha Yoga Center | Adiyogi Shiva | YOYOTVKannada
